Skip to content

Secondary Obliteration of Old Radical Cavities Using S53P4 Bioactive Glass

Efficacy of Secondary Obliteration of Chronically Discharging Old Radical Cavities Using S53P4 Bioactive Glass

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06116513
Enrollment
97
Registered
2023-11-03
Start date
2021-01-01
Completion date
2024-01-01
Last updated
2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastoid Cavity

Brief summary

In canal wall down surgeries, the posterior bony wall of the external auditory canal (EAC) is removed to increase exposure. The creation of a so-called radical cavity comes with several possible disadvantages, such as higher rates of postoperative otorrhea and purulence, pain, adherence to water precautions and dizziness. Secondary obliteration of the mastoid cavity and reconstruction of the posterior wall of the EAC can help alleviate these symptoms. Our goal is to study the efficacy of secondary obliteration using S53P4 bioactive glass as obliteration material. This bioactive glass has several important characteristics, such as retaining of volume over time and antibacterial effects. The main outcome will be postoperative otorrhea as indicated by the Merchant grading scale.

Interventions

DEVICES53P4 bioactive glass granules

During revision surgery, all infectious material would be removed and subsequently the posterior wall of the external ear canal would be reconstructed and the mastoid would be obliterated using S53P4 bioactive glass.

Sponsors

Diakonessenhuis, Utrecht
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Old canal wall down cavity * Operated between 2011 and 2022

Exclusion criteria

* Middle ear cholesteatoma * Previous obliteration

Design outcomes

Primary

MeasureTime frameDescription
Number or participants with a dry ear pre- and postoperativelyAt 1, 3 and 5-year postoperatively.Postoperative otorrhea as indicated by the Merchant grading system. Grade 0-1 was defined as control of infection and grade 2-3 was defined as failure.

Secondary

MeasureTime frameDescription
Pre- and postoperative air conductionpre-operatively, in the first 6 months following surgery and 6-12 months postoperativelyAudiological outcomes pre-operatively, compared to early postoperatively (\<6months) and late postoperatively (\>6months). Evaluated in the audiometry is the air conduction in decibel.
Pre- and postoperative air-bone gappre-operatively, in the first 6 months following surgery and 6-12 months postoperativelyAudiological outcomes pre-operatively, compared to early postoperatively (\<6months) and late postoperatively (\>6months). Evaluated in the audiometry is the air-bone gap in decibel.
The number of patients with postoperative surgical complicationsFirst year following surgeryComplications that occured within the first year following surgery

Countries

Netherlands

Contacts

Primary ContactLeij-Halfwerk, Msc, Ir
Wetenschapsbureau@diakhuis.nl088-250 6172

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026